Cannabics patent granted with enabling technology to personalize Cannabinoid diagnostics and treatment for Cancer patients PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office of the State of Israel. The Patent Office intends to grant Cannabics the patent for its method of high throughput screening ofRead more
- Vertically integrated cannabis firm Ascend Wellness raises $55 million for expansion
- Lifeline Biotechnologies Updates Shareholders and The Public
- Financial Gravity Selects Securities Transfer Corporation as Transfer Agent
- Wayfair Reports 58% Increase in Direct Retail Sales for Peak Five-Day Holiday Shopping Weekend
- Marijuana tech firm Metrc gets $50M with help from Snoop Dogg, Tiger Global
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More